GLP-1 and weight-loss medications and psilocybin.
14 records in this group. None has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.
Also searched as GLP-1 · GLP1 · weight-loss shot · weight loss shot · weight-loss injection · skinny shot
01 What the evidence covers
Best evidence available per medication| 14 | No psilocybin data No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts |
02 Each medication
A to ZPeptides
Both parts slow stomach emptying, which may delay psilocybin absorption and add to nausea. Also, semaglutide's stomach side effects can lead to dehydration.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Type 2 diabetes (with diet and exercise); Lowering risk of heart attack, stroke, and cardiovascular death in type 2 diabetes
Its nausea may add to psilocybin's, and it may delay psilocybin's onset (untested). Also, with insulin or a sulfonylurea, blood sugar can drop too low.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Type 2 diabetes (with diet and exercise)
Its nausea may add to psilocybin's nausea. Also, with insulin or a sulfonylurea, blood sugar can drop too low.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Type 2 diabetes (with diet and exercise)
It may slow psilocybin absorption and add nausea, and its insulin can lower blood sugar. Stopping or pausing it can raise blood sugar.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Type 2 diabetes (with diet and exercise)
It may slow psilocybin absorption and add nausea, and its insulin can lower blood sugar. Stopping or pausing it can raise blood sugar.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Type 2 diabetes (with diet and exercise); Reducing heart attack, stroke and cardiovascular death risk in type 2 diabetes with heart disease
Its nausea may add to psilocybin's, and its effect on psilocybin absorption is unknown. Also, blood sugar can drop when used with insulin or sulfonylureas.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Weight management in adults with obesity, or overweight with a weight-related condition (with diet and exercise)
Not studied with psilocybin; its label warns of psychosis, mania and suicidal thinking, so overlap with psilocybin's effects is possible. Also, it lowers seizure threshold.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Chronic weight management (obesity, or overweight with a weight-related condition)
It slows stomach emptying, which may delay or reduce psilocybin absorption and add nausea.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Weight loss in overweight adults (over-the-counter, with reduced-calorie, low-fat diet); Obesity management, weight maintenance and reducing weight regain (prescription)
Not studied with psilocybin; it causes oily, urgent stools, so added stomach upset is possible. Also, it is a probable rare cause of liver injury.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Obesity (short-term, with diet, exercise and behavior change)
Not studied with psilocybin; it raises blood pressure and heart rate, so an added rise is possible.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Weight management in obesity (adults and ages 12+) or adult overweight with a weight-related condition (with diet and exercise)
Phentermine's rise in blood pressure and heart rate may add to psilocybin's. Stopping it suddenly after regular use can cause seizures.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
- RetatrutideEvidence: No psilocybin data
Peptides
It slows stomach emptying, which may delay psilocybin absorption and add nausea, and it raises heart rate. Also, outside a trial, product content is unverified.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Type 2 diabetes (with diet and exercise); Lowering heart attack, stroke and cardiovascular death risk in type 2 diabetes
Its nausea can add to psilocybin's, and it may delay absorption of oral psilocybin. Also, blood sugar can drop with insulin or sulfonylureas.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Type 2 diabetes (with diet and exercise); Lowering risk of major cardiovascular events in type 2 diabetes
It may delay absorption of oral psilocybin (not studied), and its nausea can add to psilocybin's. Also, blood sugar can drop with insulin or sulfonylureas.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
03 Properties the records flag
Records with each flag| 10 | Slows gastric emptying |
| 8 | Dehydration or electrolyte risk |
| 8 | Hypoglycemia risk |
| 7 | Raises blood pressure or heart rate |
| 4 | Withdrawal or rebound if stopped abruptly |
| 3 | Psychiatric reactions |
| 1 | Liver injury |
| 1 | Lowers seizure threshold or carries seizure risk |
| 1 | Opioid blocker |
| 1 | Sedating or CNS depressant |
| 1 | Speeds up drug metabolism |
Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.
04 State rules
Official text governsNo provision names these medications or this group.
Rule 2.2(A)(9): a facilitator must tell prospective participants in writing that anyone taking a psychotropic medication identified as a risk factor on the safety screen must meet one of the 2.2(A)(7) conditions. 2 of the 14 medications in this group are psychotropic; the rule applies when one is identified as a risk factor on a participant's screen.
No provision names these medications or this group.
Rules not final; the proposed rules reviewed name no medication in this group.
05 Studies cited in this group
Records citing eachRelated classes
- Diabetes medications7 shared
- Stimulants and ADHD medications2 shared
Records reviewed 2026-10-03 to 2026-10-14. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z